| Literature DB >> 30730218 |
Lambert Nzungize1, Md Kaisar Ali1, Xiaoyu Wang1, Xue Huang1, Wenmin Yang1, Xiangke Duan1, Shuangquan Yan1, Chunyan Li1, Abualgasim Elgaili Abdalla1,2, Ponmani Jeyakkumar3, Jianping Xie1.
Abstract
Tuberculosis, especially multidrug resistant cases, remains an enormous public health threat. Mycobacterium tuberculosis metC (Rv3340) an enzyme involved in methionine biosynthesis was identified and characterised for antimicrobial susceptibility. We reported that the overexpression of Rv3340 in Mycobacterium smegmatis (Ms_Rv3340) produces hydrogen sulphide (H2S) for its energy in harsh conditions. The produced H2S sustained Ms_Rv3340 against streptomycin, whereas the chemical inhibition of H2S caused streptomycin lethality to Ms_Rv3340. Further analysis showed that cysteine-H2O2 treatment of Ms-Rv3340 initiated DNA damage via Fenton reaction. Ms_Rv3340 downregulated the expression levels of three streptomycin responsive genes. To our knowledge, no study has been previously reported that M. tuberculosis metC (Rv3340) can generates H2S modulating resistant to streptomycin which provides a greater perception toward the treatment and control of tuberculosis.Entities:
Keywords: Mycobacterium tuberculosis Rv3340; hydrogen sulphide; metC; methionine; streptomycin
Mesh:
Substances:
Year: 2019 PMID: 30730218 DOI: 10.1080/1061186X.2019.1579820
Source DB: PubMed Journal: J Drug Target ISSN: 1026-7158 Impact factor: 5.121